+0.4%
38,322
38,172
Consolidated revenue stood at Rs 38,322 crore for Q1FY21 vs Rs 38,172 crore for Q1FY20, a rise of 0.39% YoY. Dollar revenue down by 7.1% at USD 5,059 Millioin while constant currency revenue growth slipped to -6.9%.
The company saw a strong order book of USD 6.9 billion for the quarter, with small and large orders.
The company has declared a dividend of Rs 5 per share for the quarter.
On the geographic front, Continental Europe and Latin America saw a positive growth, while all other geographies saw a decline, India was hit the hardest.
The Life-sciences and Healthcare vertical saw growth while the Retail segment was hit the hardest due to the COVID-19 outbreak.
-1.8%
9,048
9,220
The EBIT stood at Rs 9,048 crore for Q1FY21 vs Rs 9,220 crore for Q1FY20, a decline of 1.87% YoY. The EBIT Margin stood at 23.6% for the quarter vs. 25.08%
The company saw a decline in the margins owing the decline in the demand, which is expected to start rising from Q4 onwards.
-13.8%
7,008
8,131
The PAT stood at Rs 7,008 crore for Q1FY21 vs Rs 8,131 crore for Q1FY20, a decline of 13.8% YoY. The PAT Margin stood at 18.3% for the quarter.
PREVIOUS
CURRENT
38,322
38,172
INLINE
REVENUE
-0.4%
9,048
9,220
-1.8%
MISSES
EBITDA
7,008
8,131
-13.8%
MISSES
PROFIT